AstraZeneca (AZN) News Today → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free AZN Stock Alerts $78.02 +1.25 (+1.63%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 9:41 PM | marketbeat.comEagle Asset Management Inc. Sells 597,005 Shares of AstraZeneca PLC (NASDAQ:AZN)Eagle Asset Management Inc. trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 30.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,347,965 shares of the company's stock afterJune 1 at 2:38 PM | marketbeat.comShort Interest in AstraZeneca PLC (NASDAQ:AZN) Declines By 10.1%AstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 7,670,000 shares, a decrease of 10.1% from the April 30th total of 8,530,000 shares. Based on an average daily trading volume, of 5,310,000 shares, the short-interest ratio is currently 1.4 days.June 1 at 3:50 AM | americanbankingnews.comAstraZeneca (NASDAQ:AZN) PT Raised to $85.00 at ArgusMay 31 at 4:20 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Position Boosted by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 147,251 shares of the company's stockMay 30 at 4:46 PM | marketbeat.comSanders Capital LLC Has $988.97 Million Position in AstraZeneca PLC (NASDAQ:AZN)Sanders Capital LLC increased its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 39.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,684,066 shares of the company's stoMay 30 at 2:23 PM | marketbeat.comAstraZeneca (NASDAQ:AZN) Price Target Increased to $85.00 by Analysts at ArgusArgus boosted their price target on shares of AstraZeneca from $80.00 to $85.00 and gave the stock a "buy" rating in a research note on Thursday.May 30 at 8:24 AM | americanbankingnews.comThe Goldman Sachs Group Begins Coverage on AstraZeneca (NASDAQ:AZN)May 30 at 7:00 AM | fool.comThis Pharma Stock Is Poised to Keep Outperforming the S&P 500May 30 at 7:00 AM | prnewswire.comCompugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating RilvegostomigMay 29 at 11:55 PM | marketbeat.com26,252 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Catalytic Wealth RIA LLCCatalytic Wealth RIA LLC acquired a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 26,252 shares of the company's stock, valued at approMay 29 at 5:31 PM | msn.comFusion shareholders give green light to AstraZeneca acquisitionMay 29 at 2:41 PM | msn.comAmgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's DrugMay 29 at 10:07 AM | fool.comAstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the StockMay 29 at 8:06 AM | fool.comAstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?May 28, 2024 | reuters.comUS FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatmentMay 28, 2024 | msn.comWhy Is AstraZeneca Stock Trading Lower On Tuesday?May 27, 2024 | msn.comAstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: ReportMay 27, 2024 | marketbeat.comUS Bancorp DE Has $12.57 Million Stake in AstraZeneca PLC (NASDAQ:AZN)US Bancorp DE raised its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 20.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 186,629 shares of the company's stock after purchasing an additional 31,252 shares dMay 27, 2024 | markets.businessinsider.comAZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical SignificanceMay 27, 2024 | businesswire.comDatopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trialMay 27, 2024 | businesswire.comDatopotamab Deruxtecan Showed Clinically Meaningful Overall Survival Improvement Versus Chemotherapy in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 TrialMay 25, 2024 | marketbeat.comOrion Portfolio Solutions LLC Raises Stake in AstraZeneca PLC (NASDAQ:AZN)Orion Portfolio Solutions LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 10.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 140,712 shares oMay 25, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) is Primecap Management Co. CA's 10th Largest PositionPrimecap Management Co. CA cut its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 2.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 42,987,075 shares of the company's stock after selling 902,2May 24, 2024 | finance.yahoo.comHere's Why We Think AstraZeneca (LON:AZN) Is Well Worth WatchingMay 23, 2024 | marketbeat.comAssetmark Inc. Buys 15,642 Shares of AstraZeneca PLC (NASDAQ:AZN)Assetmark Inc. boosted its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 11.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 154,906 shares of the company's stock after purchasing an additional 1May 23, 2024 | businesswire.comAstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)May 23, 2024 | americanbankingnews.comAstraZeneca (NASDAQ:AZN) Hits New 52-Week High at $78.53May 22, 2024 | prnewswire.comNona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted TherapiesMay 22, 2024 | benzinga.comHere's How Much You Would Have Made Owning AstraZeneca Stock In The Last 5 YearsMay 22, 2024 | marketbeat.comWells Fargo & Company MN Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)Wells Fargo & Company MN raised its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 7.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,045,394 shares of the company's stockMay 22, 2024 | msn.comAstra Aims to Almost Double Sales to $80 Billion by 2030May 22, 2024 | businesswire.comAstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024May 21, 2024 | investopedia.comAstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'May 21, 2024 | fortune.comAstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030May 21, 2024 | ft.comAstraZeneca to build Chinese supply chain as US-Sino tensions increaseMay 21, 2024 | msn.comAstraZeneca (NASDAQ:AZN) Aims for $80B Annual Revenue by 2030May 21, 2024 | marketbeat.comAstraZeneca (NASDAQ:AZN) Hits New 1-Year High at $78.53AstraZeneca (NASDAQ:AZN) Hits New 12-Month High at $78.53May 21, 2024 | investing.comAstraZeneca aims for $80 billion in total revenue by 2030May 21, 2024 | marketbeat.comMckinley Capital Management LLC Sells 18,185 Shares of AstraZeneca PLC (NASDAQ:AZN)Mckinley Capital Management LLC lowered its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 41.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,877 shares of the company's stock afMay 21, 2024 | msn.comAstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline ExpansionMay 21, 2024 | msn.comAstraZeneca shares rise as pharma group unveils 2030 revenue targetMay 21, 2024 | msn.comAstraZeneca projects $80B in revenue by 2030May 21, 2024 | markets.businessinsider.comAstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New MedicinesMay 21, 2024 | msn.comAstraZeneca kicks off ‘new era of growth’ with aim to hit $80 billion of sales by 2030May 21, 2024 | msn.comAstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline ExpansionMay 21, 2024 | cnbc.comAstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicinesMay 21, 2024 | proactiveinvestors.comAstraZeneca aims to boost revenues to $80bn by 2030May 21, 2024 | reuters.comAstraZeneca aims to deliver $80 billion in total revenue by 2030May 21, 2024 | businesswire.comAstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030May 20, 2024 | marketbeat.comFranklin Resources Inc. Sells 1,511,019 Shares of AstraZeneca PLC (NASDAQ:AZN)Franklin Resources Inc. lessened its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 13.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,805,500 shares of the company Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AZN Media Mentions By Week AZN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.870.77▲Average Medical News Sentiment AZN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼2516▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and Company News Novo Nordisk A/S News Johnson & Johnson News Merck & Co., Inc. News AbbVie News Novartis News Abbott Laboratories News Pfizer News Sanofi News Vertex Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss Ratings“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
